Yttrium-90 ibritumomab tiuxetan as a single agent in patients with pretreated B-cell lymphoma: Evaluation of the long-term outcome

Pier Luigi Zinzani, Letizia Gandolfi, Vittorio Stefoni, Stefano Fanti, Mariapaola Fina, Cinzia Pellegrini, Gian Carlo Montini, Enrico Derenzini, Alessandro Broccoli, Lisa Argnani, Stefano Pileri, Michele Baccarani

Research output: Contribution to journalArticlepeer-review

Fingerprint Dive into the research topics of 'Yttrium-90 ibritumomab tiuxetan as a single agent in patients with pretreated B-cell lymphoma: Evaluation of the long-term outcome'. Together they form a unique fingerprint.

Medicine & Life Sciences